These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1783533)

  • 21. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
    Sherman DG; Atkinson RP; Chippendale T; Levin KA; Ng K; Futrell N; Hsu CY; Levy DE
    JAMA; 2000 May; 283(18):2395-403. PubMed ID: 10815082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study.
    Abciximab in Ischemic Stroke Investigators
    Stroke; 2000 Mar; 31(3):601-9. PubMed ID: 10700492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular safety of lubeluzole (Prosynap(R)) in patients with ischemic stroke.
    Hacke W; Lees KR; Timmerhuis T; Haan J; Hantson L; Hennerici M; Diener HC
    Cerebrovasc Dis; 1998; 8(5):247-54. PubMed ID: 9712921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of naloxone on deficits after aneurysmal subarachnoid hemorrhage.
    Bell BA; Miller JD; Neto NG; O'Neill P; Laughton LM
    Neurosurgery; 1985 Apr; 16(4):498-501. PubMed ID: 3157881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
    Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
    Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
    Kay R; Wong KS; Yu YL; Chan YW; Tsoi TH; Ahuja AT; Chan FL; Fong KY; Law CB; Wong A
    N Engl J Med; 1995 Dec; 333(24):1588-93. PubMed ID: 7477193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone.
    Hosobuchi Y; Baskin DS; Woo SK
    Science; 1982 Jan; 215(4528):69-71. PubMed ID: 6274019
    [No Abstract]   [Full Text] [Related]  

  • 33. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.
    Haley EC; Brott TG; Sheppard GL; Barsan W; Broderick J; Marler JR; Kongable GL; Spilker J; Massey S; Hansen CA
    Stroke; 1993 Jul; 24(7):1000-4. PubMed ID: 8322373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervene (Nalmefene) in acute ischemic stroke : final results of a phase III efficacy study. The Cervene Stroke Study Investigators.
    Clark WM; Raps EC; Tong DC; Kelly RE
    Stroke; 2000 Jun; 31(6):1234-9. PubMed ID: 10835438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
    Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
    Stroke; 2005 Apr; 36(4):880-90. PubMed ID: 15731473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke.
    Huczynski J; Kostka-Trabka E; Sotowska W; Bieron K; Grodzinska L; Dembinska-Kiec A; Pykosz-Mazur E; Peczak E; Gryglewski RJ
    Stroke; 1985; 16(5):810-4. PubMed ID: 3901421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.
    Elting JW; Sulter GA; Kaste M; Lees KR; Diener HC; Hommel M; Versavel M; Teelken AW; De Keyser J
    Stroke; 2002 Dec; 33(12):2813-8. PubMed ID: 12468775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of high dose naloxone in acute stroke: possible side-effects.
    Barsan WG; Olinger CP; Adams HP; Brott TG; Eberle R; Biller J; Biros M; Marler J
    Crit Care Med; 1989 Aug; 17(8):762-7. PubMed ID: 2752771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.